• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Teva Pharmaceutical Industries

nyse
Pharma

Teva rides growth momentum through Q2, boosts '24 sales outlook

Teva has boosted its revenue and profit outlook for the year after reporting a strong quarter for its generics business.
Eric Sagonowsky Jul 31, 2024 9:11am
Business documents being signed

Teva snares up to $150M in Abingworth funding for inhaler program

Apr 1, 2024 10:51am
Biogen

Biogen notches another Tecfidera patent win in Europe

Dec 19, 2023 9:30am
Federal Trade Commission

AbbVie, Boehringer and more face FTC ire for 'improper' patents

Nov 7, 2023 2:22pm
legal criminal lady justice court case law trial

Teva seeks appeal of recent ruling in federal kickbacks case

Jul 27, 2023 11:30am
signing contract

Exelixis, Teva settle patent litigation with 2031 license

Jul 24, 2023 10:05am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings